Medical Condition News

RSS

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Medtronic, Inc., today announced the imminent release of the pivotal U.S. data on its Resolute drug-eluting stent at ACC.11, the 60th Annual Scientific Session & Expo of the American College of Cardiology, which takes place April 2-5 in New Orleans.

29 Mar 2011

FDA approves Medtronic's Protecta implantable defibrillators

Medtronic, Inc. today announced U.S. Food and Drug Administration approval of the Protecta portfolio of implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

29 Mar 2011

CPRIT awards $36.7 million grant to UT Southwestern for cancer research

The Cancer Prevention and Research Institute of Texas has awarded more than $36.7 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer investigators.

29 Mar 2011

Study: Marijuana use may affect cognitive skills in patients with MS

Any possible pain relief that marijuana has for people with multiple sclerosis may be outweighed by the drug's apparent negative effect on thinking skills, according to research published in the March 29, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

29 Mar 2011

Inflammatory bowel disease in children - Delays in diagnosis common

Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children’s Center.

28 Mar 2011

Early symptoms of Parkinson's disease may be revealed in dream sleep

During a large-scale study of the socioeconomic costs of this neurodegenerative disease, Danish researchers, some from the University of Copenhagen, discovered that very early symptoms of Parkinson's disease may be revealed in dream or REM sleep.

28 Mar 2011

Angioplasty procedures have minimal risk

Understanding that angioplasty—a medical treatment used by interventional radiologists to widen the veins in the neck and chest to improve blood flow—is safe may encourage additional studies for its use as a treatment option for individuals with multiple sclerosis, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

28 Mar 2011

Alternative anti-inflammatory approach to epilepsy management

If common anticonvulsant drugs fail to manage epileptic seizures, then perhaps the anti-inflammatory route is the way to go. That's according to Mattia Maroso and colleagues from the Mario Negri Institute for Pharmacological Research in Milan, Italy, who found that giving mice repeated doses of a specific enzyme inhibitor significantly reduced both chronic epileptic activity and acute seizures.

28 Mar 2011

ADDF awards Yuma $249,810 grant for Alzheimer's research

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $249,810 to Yuma Therapeutics Corporation to develop small molecules to treat Alzheimer's disease.

28 Mar 2011

ActiveSite's ASP-440 plasma kallikrein inhibitor effective in reducing diabetes-induced blood-retinal barrier breakdown

ActiveSite Pharmaceuticals, Inc., announced today the online publication of a study in the journal Diabetes that describes the effectiveness of its novel plasma kallikrein inhibitor ASP-440 in reducing blood-retinal barrier breakdown in a rodent model of diabetes.

28 Mar 2011

Ascension launches TITAN Modular Shoulder Fracture Prosthesis

Ascension Orthopedics, Inc., a world leader in PyroCarbon orthopedic devices, announces the market release of the TITAN Modular Shoulder Fracture Prosthesis. The TITAN Modular Total Shoulder System now provides a unique way to address difficult fracture procedures. The system's modularity allows the surgeon to fit patient anatomy by independently adjusting the height of the modular body and stem without need for jigs or use of cement.

28 Mar 2011

CRANE ChemPharma to launch Saunders PV Life Science Diaphragm and S360 Actuator at INTERPHEX 2011

CRANE ChemPharma Flow Solutions is pleased to introduce two new products from its Saunders brand during INTERPHEX 2011.

28 Mar 2011

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously treated with surgical resection of a Stage I/II colon cancer tumor or Stage I rectal cancer tumor.

28 Mar 2011

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.

28 Mar 2011

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced enrollment of the first patient in the company's JETSTREAM G3 Calcium Study, a prospective, single-arm, multi-center registry to evaluate the treatment effects of the JETSTREAM G3 System in patients with moderate to severely calcified peripheral artery disease.

28 Mar 2011

Phase 2a study of DARA BioSciences KRN5500 in treatment of cancer pain reaches primary end-point

Researchers studying a new medication for neuropathic pain have reported intriguing findings about placebo response versus drug response from a Phase 2a proof-of-concept study. They presented their findings in a poster session at the 2011 International Conference on Accelerating the Development of Enhanced Pain Treatments.

28 Mar 2011

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

28 Mar 2011

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.

28 Mar 2011

First open fetal surgery to treat lung malformations performed at Texas Children's Hospital

Experts from Texas Children's Fetal Center published a study that appears in volume 46, issue 2 of the Journal of Pediatric Surgery documenting the first successful cases of open fetal surgery to treat fetal lung malformations in the Southern U.S.

28 Mar 2011

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

AVEO Pharmaceuticals, Inc. today announced that preclinical data on tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, and the company's monoclonal antibody pipeline will be presented during poster sessions at the American Association for Cancer Research 102nd Annual Meeting 2011 being held April 2-6, 2011 in Orlando, Fla.

28 Mar 2011

Medical Condition News

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

FDA approves Medtronic's Protecta implantable defibrillators

CPRIT awards $36.7 million grant to UT Southwestern for cancer research

Study: Marijuana use may affect cognitive skills in patients with MS

Inflammatory bowel disease in children - Delays in diagnosis common

Early symptoms of Parkinson's disease may be revealed in dream sleep

Angioplasty procedures have minimal risk

Alternative anti-inflammatory approach to epilepsy management

ADDF awards Yuma $249,810 grant for Alzheimer's research

ActiveSite's ASP-440 plasma kallikrein inhibitor effective in reducing diabetes-induced blood-retinal barrier breakdown

Ascension launches TITAN Modular Shoulder Fracture Prosthesis

CRANE ChemPharma to launch Saunders PV Life Science Diaphragm and S360 Actuator at INTERPHEX 2011

Everist Genomics announces global launch of OncoDefender-CRC colorectal cancer assay

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Phase 2a study of DARA BioSciences KRN5500 in treatment of cancer pain reaches primary end-point

Cancer drug Gleevec may hold promise against scleroderma: Study

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

First open fetal surgery to treat lung malformations performed at Texas Children's Hospital

AVEO to present tivozanib preclinical data, monoclonal antibody pipeline at AACR meeting

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News